LobbyingBausch & Lomb lobbying by quarter
Bausch & Lomb BLCO's latest lobbying report covers Q2 2026, at $30K. Its first report covers Q2 2026; the issues it reports most are Medical/Disease Research/Clinical Labs and Pharmacy.
Bausch & LombBLCO
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 2 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$15K · 1 reports
- Pharmacy$15K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)1 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| H.A. Cumber & Company | $30K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| HUSEIN CUMBER | Assistant to the Secretary, USDOT; Deputy Chief of Staff, USDOT | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | H.A. Cumber & Company | $30K |
| 07/16for Q2 | H.A. Cumber & Company | Under $5,000 |